Subscribe
We explore what the Competition and Markets Authority's robust approach means for investors
Fund managers set out their views on the key issues in their area of expertise
In 2024, you don’t need to be a hedge fund giant to find useful edges beyond financial statements
Despite a tricky year for markets, they had a much better 12 months than last year
Camtek's inspection equipment is in high demand as demand for AI chips ramps up
Trader Michael Taylor asks what we can learn from company directors' sharedealings
This group’s change of primary listing venue to New York opens the door to more US deals
Investors risk missing out on key medical advancements with their pessimistic view of smaller drug developers
After a terrible 12 months, there are good reasons to anticipate a better 2024 for this mid-tier oil and gas company
Yes, you heard correctly: this fast-growing advisory firm offers a wide business moat and strong growth prospects